Abstract
Objective Recent advancements in GPT-4 have enabled analysis of text with visual data. Diagnosis in ophthalmology is often based on ocular examinations and imaging, alongside the clinical context. The aim of this study was to evaluate the performance of multimodal GPT-4 (GPT-4V) in an integrated analysis of ocular images and clinical text.
Methods This retrospective study included 40 patients seen in our institution with ocular pathologies. Cases were selected by a board certified ophthalmologist, to represent various pathologies and match the level for ophthalmology residents. We provided the model with each image, without and then with the clinical context. We also asked two non-ophthalmology physicians to write diagnoses for each image, without and then with the clinical context. Answers for both GPT-4V and the non-ophthalmologists were evaluated by two board-certified ophthalmologists. Performance accuracies were calculated and compared.
Results GPT-4V provided the correct diagnosis in 19/40 (47.5%) cases based on images without clinical context, and in 27/40 (67.5%) cases when clinical context was provided. Non-ophthalmologists physicians provided the correct diagnoses in 24/40 (60.0%), and 23/40 (57.5%) of cases without clinical context, and in 29/40 (72.5%) and 27/40 (67.5%) with clinical context.
Conclusion GPT-4V at its current stage is not yet suitable for clinical application in ophthalmology. Nonetheless, its ability to simultaneously analyze and integrate visual and textual data, and arrive at accurate clinical diagnoses in the majority of cases, is impressive. Multimodal large language models like GPT-4V have significant potential to advance both patient care and research in ophthalmology.
Competing Interest Statement
BSG is an employee of Character Biosciences.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
ORB of Sheba Medical Center, Israel gave ethical approval for this work (0143-23-SMC)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
